{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:18:36Z","timestamp":1783091916451,"version":"3.54.6"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["16-04-00851"],"award-info":[{"award-number":["16-04-00851"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RFBR grant","award":["18-34-00996"],"award-info":[{"award-number":["18-34-00996"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bbr.2018.10.033","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T14:05:10Z","timestamp":1540303510000},"page":"274-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish"],"prefix":"10.1016","volume":"359","author":[{"given":"Andrey D.","family":"Volgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg A.","family":"Yakovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0258-2801","authenticated-orcid":false,"given":"Konstantin A.","family":"Demin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina A.","family":"Alekseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan V.","family":"Kalueff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0306-4522(99)00487-X","article-title":"Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents","volume":"95","author":"Sarter","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2018.10.033_bib0015","series-title":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2013"},{"key":"10.1016\/j.bbr.2018.10.033_bib0020","series-title":"6 \u2013 Autonomic Nervous System, Elsevier\u2019s Integrated Review Pharmacology","first-page":"91","author":"Kester","year":"2012"},{"key":"10.1016\/j.bbr.2018.10.033_bib0025","series-title":"Small Animal Clinical Pharmacology (Second Edition)","first-page":"59","article-title":"Chapter 4 - The pharmacology of the autonomic nervous system A2","author":"Kleinz","year":"2008"},{"issue":"208","key":"10.1016\/j.bbr.2018.10.033_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-23274-9_2","article-title":"Structure-function studies of muscarinic acetylcholine receptors","author":"Leach","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2018.10.033_bib0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2183\/pjab.89.226","article-title":"Molecular properties of muscarinic acetylcholine receptors","volume":"89","author":"Haga","year":"2013","journal-title":"Proc. Japan Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.bbr.2018.10.033_bib0040","series-title":"Methods of Behavior Analysis in Neuroscience","article-title":"Frontiers in neuroscience. the revival of scopolamine reversal for the assessment of cognition-enhancing drugs","author":"Buccafusco","year":"2009"},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-007-0887-8","article-title":"The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates","volume":"199","author":"Buccafusco","year":"2008","journal-title":"Psychopharmacology"},{"issue":"3-4","key":"10.1016\/j.bbr.2018.10.033_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000350185","article-title":"Neuronal mechanisms and the treatment of motion sickness","volume":"91","author":"Schmal","year":"2013","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/WCO.0000000000000163","article-title":"Pathophysiology and treatment of motion sickness","volume":"28","author":"Golding","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/ACO.0b013e32832dba81","article-title":"Nausea and vomiting after office-based anesthesia","volume":"22","author":"Kolodzie","year":"2009","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"6","key":"10.1016\/j.bbr.2018.10.033_bib0065","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2125.1980.tb00525.x","article-title":"Some effects of atropine on short-term memory","volume":"10","author":"Wetherell","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002826-199006000-00007","article-title":"Effects of atropine on learning and memory functions in dementia","volume":"13","author":"Inzelberg","year":"1990","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2018.10.033_bib0075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0031-6997(25)07156-X","article-title":"Behavioral and electroencephalographic effects of atropine and related compounds","volume":"18","author":"Longo","year":"1966","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0080","first-page":"107","article-title":"Postoperative delirium secondary to atropine premedication","volume":"32","author":"Hammon","year":"1985","journal-title":"Anesth. Prog."},{"issue":"3 Pt 2","key":"10.1016\/j.bbr.2018.10.033_bib0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0002-9394(79)90523-3","article-title":"Mydriatic effect of anticholinergic drugs used during reversal of nondepolarizing muscle relaxants","volume":"88","author":"Schwartz","year":"1979","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.bbr.2018.10.033_bib0090","series-title":"Animal Models of Cognitive Impairment","article-title":"Frontiers in neuroscience muscarinic receptor antagonists in rats","author":"Terry","year":"2006"},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1176\/jnp.6.3.279","article-title":"Rat model of delirium: atropine dose-response relationships","volume":"6","author":"Leavitt","year":"1994","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1017\/S1461145709990095","article-title":"Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats","volume":"13","author":"Carnicella","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02341258","article-title":"Effect of atropine on learning, extinction, retention and retrieval in rats","volume":"5","author":"Bure\u0161ov\u00e1","year":"1964","journal-title":"Psychopharmacologia"},{"issue":"8","key":"10.1016\/j.bbr.2018.10.033_bib0110","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/00912700122009836","article-title":"Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers","volume":"41","author":"Ebert","year":"2001","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2018.10.033_bib0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.ftd.0000168293.48226.57","article-title":"Pharmacokinetics and pharmacodynamics in clinical use of scopolamine","volume":"27","author":"Renner","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(93)90514-I","article-title":"Impairment of working memory induced by scopolamine in rats with noradrenergic DSP-4 lesions","volume":"238","author":"Ohno","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.10.033_bib0130","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0893-133X(99)00083-4","article-title":"Scopolamine and pavlovian fear conditioning in rats: dose-effect analysis","volume":"21","author":"Anagnostaras","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2009.06.012","article-title":"Scopolamine-induced deficits in social memory in mice: reversal by donepezil","volume":"204","author":"Riedel","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.10.033_bib0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2016.08.031","article-title":"Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495","volume":"111","author":"Podkowa","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2018.10.033_bib0145","series-title":"Emergent drugs (III): Hallucinogenic Plants and Mushrooms, An. Sist. Sanit. Navar.","first-page":"505","author":"Burillo-Putze","year":"2013"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0150","first-page":"1625","article-title":"Effects of chronic scopolamine treatment on cognitive impairment and neurofilament expression in the mouse hippocampus","volume":"17","author":"Lee","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bbr.2018.10.033_bib0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tins.2014.02.011","article-title":"Zebrafish models for translational neuroscience research: from tank to bedside","volume":"37","author":"Stewart","year":"2014","journal-title":"Trends Neurosci."},{"issue":"Pt A","key":"10.1016\/j.bbr.2018.10.033_bib0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.expneurol.2017.10.004","article-title":"The developing utility of zebrafish models of neurological and neuropsychiatric disorders: a critical review","volume":"299","author":"Fontana","year":"2018","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/mp.2014.128","article-title":"Molecular psychiatry of zebrafish","volume":"20","author":"Stewart","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cca.2004.03.002","article-title":"Muscarinic acetylcholine receptors in the brain of the zebrafish (Danio rerio) measured by radioligand binding techniques","volume":"137","author":"Williams","year":"2004","journal-title":"Comp. Biochem. Physiol. Part C Toxicol. Pharmacol."},{"issue":"00","key":"10.1016\/j.bbr.2018.10.033_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pbb.2015.03.006","article-title":"Pharmacological analyses of learning and memory in zebrafish (Danio rerio)","volume":"139","author":"Bailey","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nlm.2012.09.008","article-title":"Y-Maze memory task in zebrafish (Danio rerio): the role of glutamatergic and cholinergic systems on the acquisition and consolidation periods","volume":"98","author":"Cognato Gde","year":"2012","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.bbr.2018.10.033_bib0185","series-title":"A Study of the Effects of Methylene Blue, Scopolamine, and Stress on Learning and Memory in the Zebrafish","author":"Caramillo","year":"2017"},{"issue":"2","key":"10.1016\/j.bbr.2018.10.033_bib0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neures.2010.03.003","article-title":"Scopolamine-induced learning impairment reversed by physostigmine in zebrafish","volume":"67","author":"Kim","year":"2010","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2010.09.027","article-title":"Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish","volume":"217","author":"Richetti","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.10.033_bib0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2017.11.010","article-title":"Lithium prevents scopolamine-induced memory impairment in zebrafish","volume":"664","author":"Zanandrea","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0205","first-page":"485","article-title":"Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain","volume":"23","author":"Zebrowska-Lupina","year":"1975","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.bbr.2018.10.033_bib0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.aquatox.2015.08.007","article-title":"Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology research","volume":"170","author":"Kalueff","year":"2016","journal-title":"Aquat. Toxicol."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2011.07.037","article-title":"Modeling anxiety using adult zebrafish: a conceptual review","volume":"62","author":"Stewart","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3758\/BF03195394","article-title":"EthoVision: a versatile video tracking system for automation of behavioral experiments","volume":"33","author":"Noldus","year":"2001","journal-title":"Behav. Res. Methods Instrum. Comput."},{"issue":"5","key":"10.1016\/j.bbr.2018.10.033_bib0225","doi-asserted-by":"crossref","first-page":"e36931","DOI":"10.1371\/journal.pone.0036931","article-title":"Measures of anxiety in zebrafish (Danio rerio): dissociation of black\/white preference and novel tank test","volume":"7","author":"Blaser","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbr.2018.10.033_bib0230","doi-asserted-by":"crossref","first-page":"e48865","DOI":"10.1371\/journal.pone.0048865","article-title":"From schooling to shoaling: patterns of collective motion in zebrafish (Danio rerio)","volume":"7","author":"Miller","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1515\/rns.2011.004","article-title":"Shoaling in zebrafish: what we don\u2019t know","volume":"22","author":"Miller","year":"2011","journal-title":"Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2018.10.033_bib0240","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.pnpbp.2010.09.003","article-title":"Shoaling develops with age in zebrafish (Danio rerio)","volume":"35","author":"Buske","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.10.033_bib0245","series-title":"R: A Language and Environment for Statistical Computing","first-page":"2017","author":"Team","year":"2016"},{"key":"10.1016\/j.bbr.2018.10.033_bib0250","series-title":"Elegant Graphics for Data Analysis (ggplot2)","author":"Wickham","year":"2009"},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/zeb.2016.1415","article-title":"Comparative analyses of zebrafish anxiety-like behavior using conflict-based novelty tests","volume":"14","author":"Kysil","year":"2017","journal-title":"Zebrafish"},{"key":"10.1016\/j.bbr.2018.10.033_bib0260","series-title":"Brody\u2019s Human Pharmacology E-Book","author":"Watts","year":"2009"},{"issue":"4","key":"10.1016\/j.bbr.2018.10.033_bib0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00407863","article-title":"Effects of scopolamine and atropine and their quaternized salts on avoidance behavior in the monkey","volume":"8","author":"Samuel","year":"1965","journal-title":"Psychopharmacologia"},{"issue":"25","key":"10.1016\/j.bbr.2018.10.033_bib0270","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/S0024-3205(99)00188-5","article-title":"Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland","volume":"64","author":"Moriya","year":"1999","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bbr.2018.10.033_bib0275","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(25)11335-9","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2018.10.033_bib0280","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuropharm.2016.04.027","article-title":"The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors","volume":"108","author":"Lochner","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0285","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1038\/s41598-017-15374-w","article-title":"Establishing zebrafish as a model to study the anxiolytic effects of scopolamine","volume":"7","author":"Hamilton","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/19768354.2011.642084","article-title":"Anxiolytic effects of an acetylcholinesterase inhibitor, physostigmine, in the adult zebrafish","volume":"16","author":"Cho","year":"2012","journal-title":"Animal Cells Syst."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0295","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0361-9230(97)00311-0","article-title":"The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test","volume":"45","author":"Smythe","year":"1998","journal-title":"Brain Res. Bull."},{"issue":"10","key":"10.1016\/j.bbr.2018.10.033_bib0300","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbr.2018.10.033_bib0305","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/npp.2010.131","article-title":"Scopolamine produces larger antidepressant and antianxiety effects in women than in men","volume":"35","author":"Furey","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2018.10.033_bib0310","series-title":"Treatment of Acute Anxiety Episodes in Patients Using A Fast-Acting Beta blocker \u2013 Scopolamine Combination Drug","author":"Thomas","year":"2017"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0091-3057(95)02130-2","article-title":"Muscarinic antagonists are anxiogenic in rats tested in the black-white box","volume":"54","author":"Smythe","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bbr.2018.10.033_bib0320","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/nlme.1995.1018","article-title":"Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning","volume":"63","author":"Young","year":"1995","journal-title":"Neurobiol. Learn. Mem."},{"issue":"6","key":"10.1016\/j.bbr.2018.10.033_bib0325","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0893-133X(99)00083-4","article-title":"Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis","volume":"21","author":"Anagnostaras","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0330","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-3057(87)90555-7","article-title":"Effects of scopolamine on locomotor activity and metabolic rate in mice","volume":"26","author":"Bushnell","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2018.10.033_bib0335","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fphar.2018.00293","article-title":"Commentary: establishing zebrafish as a model to study the anxiolytic effects of scopolamine","volume":"9","author":"de Abreu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2018.10.033_bib0340","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbr.2010.05.039","article-title":"Characterization of behavioral and endocrine effects of LSD on zebrafish","volume":"214","author":"Grossman","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.bbr.2018.10.033_bib0345","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0028-3932(88)90004-8","article-title":"Modelling dementia: effects of scopolamine on memory and attention","volume":"26","author":"Broks","year":"1988","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0350","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pbb.2005.04.010","article-title":"Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans","volume":"81","author":"Green","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0355","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00427761","article-title":"Effects of scopolamine and nicotine on human rapid information processing performance","volume":"82","author":"Wesnes","year":"1984","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2018.10.033_bib0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainresrev.2005.11.002","article-title":"More attention must be paid: the neurobiology of attentional effort","volume":"51","author":"Sarter","year":"2006","journal-title":"Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0365","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1074-7427(03)00070-4","article-title":"Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory?","volume":"80","author":"Sarter","year":"2003","journal-title":"Neurobiol. Learn. Mem."},{"issue":"7","key":"10.1016\/j.bbr.2018.10.033_bib0370","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/gerona\/63.7.764","article-title":"Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence","volume":"63","author":"Hshieh","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2018.10.033_bib0375","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(94)90193-7","article-title":"Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine","volume":"25","author":"Ukai","year":"1994","journal-title":"Gen. Pharmacol. Vasc. Syst."},{"issue":"1","key":"10.1016\/j.bbr.2018.10.033_bib0380","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1037\/h0076205","article-title":"Attenuation of \"acute\" habituation by scopolamine in the black-tailed prairie dog (Cynomys ludovicianus)","volume":"88","author":"Carlson","year":"1975","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.bbr.2018.10.033_bib0385","article-title":"Understanding Central Nervous System effects of deliriant hallucinogenic drugs through experimental animal models","author":"Volgin","year":"2018","journal-title":"ACS Chem. Neurosci."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818312518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818312518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:18:00Z","timestamp":1775251080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818312518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":77,"alternative-id":["S0166432818312518"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.10.033","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}